GlyCare™ LNFP I

Highly abundant fucosylated HMO

GlyCare™ LNFP I Overview

LNFP I (Lacto-N-fucopentaose I) is a highly abundant, α1-2 fucosylated HMO in human milk.  Some primary known benefits of LNFP I include modulation of the immune system, binding of toxins, and positively supporting gut health by selectively stimulating bifidobacteria.

GlyCare™ LNFP I is presently undergoing development

Immunity and Infections

HMO help support immunity. Clinical studies have reported a relationship between HMO and immune outcomes in infants. HMO are reported to support an infant’s immune system. HMO may help reduce the risk of infection. 

Gut Health and Microbiota

Clinical data suggest HMOs support intestinal health in infants. Preclinical and clinical data indicate that HMOs support the growth of beneficial bacteria/bifidobacteria. HMOs may help support the growth of beneficial bacteria/bifidobacteria which are believed to be important for immune and intestinal development and health. 

Allergy Development

Emerging data from pre-clinical models and breast milk studies suggest that HMOs may play a role reducing the incidence of certain allergic manifestations.

HMO Health Benefit Solutions

Human Milk Oligosaccharides may support a number of health benefits such as immunity and gut health in early life.

More than ingredients

Learn how DSM can help your business. Select the options below to connect your needs with the right solution.

I'd like to explore...

If the options above don't sound like you, skip ahead and contact us.

Quick Links

Food Specialties

Discover enzymes for baking, brewing, dairy and more.

Health Benefit Solutions

Solutions to address consumers' health and lifestyle needs.

Scientific Services

Science-based expertise supporting innovations that meet consumer needs.

About DSM

Our purpose is to create brighter lives for all.

Talking Nutrition

Explore new science, consumer insights, industry events and more.

Webshop

Request samples, place orders and view product documentation.